Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study
Authors
Keywords
Depression, Oxidative and nitrosative stress, Immune, Inflammation
Journal
NEUROTOXICITY RESEARCH
Volume 33, Issue 3, Pages 621-633
Publisher
Springer Nature
Online
2018-01-11
DOI
10.1007/s12640-017-9860-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activated neuro-oxidative and neuro-nitrosative pathways at the end of term are associated with inflammation and physio-somatic and depression symptoms, while predicting outcome characteristics in mother and baby
- (2017) Chutima Roomruangwong et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study
- (2017) Adrian L. Lopresti et al. JOURNAL OF AFFECTIVE DISORDERS
- Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies
- (2017) Adrian L Lopresti JOURNAL OF PSYCHOPHARMACOLOGY
- Clinical Use of Curcumin in Depression: A Meta-Analysis
- (2017) Qin Xiang Ng et al. Journal of the American Medical Directors Association
- Increased Root Canal Endotoxin Levels are Associated with Chronic Apical Periodontitis, Increased Oxidative and Nitrosative Stress, Major Depression, Severity of Depression, and a Lowered Quality of Life
- (2017) Cinthya Gomes et al. MOLECULAR NEUROBIOLOGY
- Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis
- (2017) Cristiano A. Köhler et al. MOLECULAR NEUROBIOLOGY
- Effects of curcumin on HDL functionality
- (2017) Shiva Ganjali et al. PHARMACOLOGICAL RESEARCH
- Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders
- (2017) Luiz Gustavo Piccoli de Melo et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Curcumin, mitochondrial biogenesis, and mitophagy: Exploring recent data and indicating future needs
- (2016) Marcos Roberto de Oliveira et al. BIOTECHNOLOGY ADVANCES
- Curcumin in depressive disorders: An overview of potential mechanisms, preclinical and clinical findings
- (2016) Fernanda Neutzling Kaufmann et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model
- (2016) Anastasiya Slyepchenko et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Abnormal gene expression of proinflammatory cytokines and their membrane-bound receptors in the lymphocytes of depressed patients
- (2016) Hooriyah S. Rizavi et al. PSYCHIATRY RESEARCH
- An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial
- (2015) Habibollah Esmaily et al. Chinese Journal of Integrative Medicine
- Curcumin and major depression: A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change
- (2015) Adrian L. Lopresti et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Therapeutic role of curcumin in oxidative DNA damage caused by formaldehyde
- (2015) Gulay Ciftci et al. MICROSCOPY RESEARCH AND TECHNIQUE
- The Role of Curcumin Administration in Patients with Major Depressive Disorder: Mini Meta-Analysis of Clinical Trials
- (2015) Dalia Al-Karawi et al. PHYTOTHERAPY RESEARCH
- A Meta-Analysis of Oxidative Stress Markers in Depression
- (2015) Tao Liu et al. PLoS One
- TRYCAT Pathways Link Peripheral Inflammation, Nicotine, Somatization and Depression in the Etiology and Course of Parkinson’s Disease
- (2014) George Anderson et al. CNS & Neurological Disorders-Drug Targets
- Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study
- (2014) Adrian L. Lopresti et al. JOURNAL OF AFFECTIVE DISORDERS
- Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism–smoking interactions differentially predict the odds of major depression and bipolar disorder
- (2014) Chiara Cristina Bortolasci et al. JOURNAL OF AFFECTIVE DISORDERS
- Investigation of the Efficacy of Adjunctive Therapy with Bioavailability-Boosted Curcuminoids in Major Depressive Disorder
- (2014) Yunes Panahi et al. PHYTOTHERAPY RESEARCH
- The Integrative Management of Treatment-Resistant Depression: A Comprehensive Review and Perspectives
- (2014) Andre F. Carvalho et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects
- (2014) Ole Köhler et al. JAMA Psychiatry
- Curcumin and piperine abrogate lipid and protein oxidation induced by d-galactose in rat brain
- (2013) David Banji et al. BRAIN RESEARCH
- Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts
- (2013) Heber Odebrecht Vargas et al. JOURNAL OF AFFECTIVE DISORDERS
- CRP, IL-6 and depression: A systematic review and meta-analysis of longitudinal studies
- (2013) Vyara Valkanova et al. JOURNAL OF AFFECTIVE DISORDERS
- Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial
- (2013) Jayesh Sanmukhani et al. PHYTOTHERAPY RESEARCH
- The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder
- (2012) Piotr Gałecki et al. JOURNAL OF AFFECTIVE DISORDERS
- Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects
- (2012) Adrian L Lopresti et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance and therapeutic implications
- (2012) S Moylan et al. MOLECULAR PSYCHIATRY
- New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors
- (2012) Michael Maes et al. INFLAMMOPHARMACOLOGY
- IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: New pathways that underpin the inflammatory and neuroprogressive pathophysiology
- (2011) Michael Maes et al. JOURNAL OF AFFECTIVE DISORDERS
- Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression
- (2011) Yang Liu et al. JOURNAL OF AFFECTIVE DISORDERS
- Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression
- (2011) Brian Leonard et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Stopping Randomized Trials Early for Benefit and Estimation of Treatment EffectsSystematic Review and Meta-regression Analysis
- (2010) Dirk Bassler JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
- (2010) M. Maes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
- (2010) Michael Maes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
- (2009) M Bryant Howren et al. PSYCHOSOMATIC MEDICINE
- Curcumin Suppresses the Induction of Indoleamine 2,3-Dioxygenase by Blocking the Janus-activated Kinase-Protein Kinase Cδ-STAT1 Signaling Pathway in Interferon-γ-stimulated Murine Dendritic Cells
- (2008) Young-Il Jeong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression
- (2008) Michael Maes et al. METABOLIC BRAIN DISEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More